Yan J Sheng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Liquid Chromatography

Respiratory Syndrome Coronavirus

Candida Albicans

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yan J Sheng, Syuan-Ting A Kuo, Tingyuan Yang, Hanyuan E Zhang, David H Russell, Xin Yan, Shiqing Xu, Wenshe Ray Liu, Carol A Fierke
BRD4354 Is a Potent Covalent Inhibitor against the SARS-CoV-2 Main Protease. Biochemistry (2024)
Yan J Sheng, Syuan-Ting A Kuo, Tingyuan Yang, Hanyuan E Zhang, David H Russell, Xin Yan, Shiqing Xu, Wenshe Ray Liu, Carol A Fierke
BRD4354 Is a Potent Covalent Inhibitor against the SARS-CoV-2 Main Protease. Biochemistry (2024)
Yan J Sheng, Syuan-Ting A Kuo, Tingyuan Yang, Hanyuan E Zhang, David H Russell, Xin Yan, Shiqing Xu, Wenshe Ray Liu, Carol A Fierke
BRD4354 Is a Potent Covalent Inhibitor against the SARS-CoV-2 Main Protease. Biochemistry (2024)
Yan J Sheng, Syuan-Ting A Kuo, Tingyuan Yang, Hanyuan E Zhang, David H Russell, Xin Yan, Shiqing Xu, Wenshe Ray Liu, Carol A Fierke
BRD4354 Is a Potent Covalent Inhibitor against the SARS-CoV-2 Main Protease. Biochemistry (2024)